Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Continual low-dose metronomic chemotherapy as potentially preferable to...

Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies ( Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel )

Looking for biomarkers in metronomic chemotherapy

Prof Guido Bocci - University of Pisa, Pisa, Italy

Looking for biomarkers in metronomic chemotherapy ( Prof Guido Bocci - University of Pisa, Pisa, Italy )

New metronomic approach to neuroblastoma

Prof Frank Berthold - University Hospital Köln, Köln, Germany

New metronomic approach to neuroblastoma ( Prof Frank Berthold - University Hospital Köln, Köln, Germany )

Cost-effectiveness of metronomic approach to neuroblastoma and its use in...

Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK

Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )

Advances in multiple myeloma: Expert panel discussion

Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios...

Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )

Impact of biomarker-integrated approaches of targeted therapy for lung cancer...

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Networking and collaborating across borders in sub-Saharan Africa

Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...

Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Systems medicine approach to optimise drugs and drug combinations for...

Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland

Systems medicine approach to optimise drugs and drug combinations for individual AML patients ( Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland )

Work of the WIN consortium and challenges of personalised cancer therapy

Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston...

Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )

Molecular investigations of immune cells and tumour environment: The ovarian...

Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland

Molecular investigations of immune cells and tumour environment: The ovarian cancer model ( Dr George Coukos - Ludwig Center for Cancer Research, Epalinges, Switzerland )

More from ecancer